Found: 23
Select item for more details and to access through your institution.
Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 4, p. 1056, doi. 10.1093/cid/ciad677
- By:
- Publication type:
- Article
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 547, doi. 10.1093/cid/ciad276
- By:
- Publication type:
- Article
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 1980, doi. 10.1093/cid/ciad031
- By:
- Publication type:
- Article
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e460, doi. 10.1093/cid/ciac381
- By:
- Publication type:
- Article
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S159, doi. 10.1093/cid/ciac439
- By:
- Publication type:
- Article
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1515, doi. 10.1093/cid/ciab687
- By:
- Publication type:
- Article
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 3, p. 235, doi. 10.1093/infdis/jiad061
- By:
- Publication type:
- Article
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 5, p. 797, doi. 10.1093/infdis/jiac118
- By:
- Publication type:
- Article
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 10, p. 1694, doi. 10.1093/infdis/jiab619
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period -- IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023
- Published in:
- MMWR Supplements, 2023, v. 72, n. 1, p. 463
- By:
- Publication type:
- Article
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021–April 2022.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 1, p. 1, doi. 10.1093/ofid/ofac698
- By:
- Publication type:
- Article
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period -- IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2023, v. 72, n. 17, p. 463, doi. 10.15585/mmwr.mm7217a3
- By:
- Publication type:
- Article
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years -- IVY Network, 18 States, September 8-November 30, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 51/52, p. 1625, doi. 10.15585/mmwr.mm715152e2
- By:
- Publication type:
- Article
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 42, p. 1327, doi. 10.15585/mmwr.mm7142a3
- By:
- Publication type:
- Article
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 12, p. 459
- By:
- Publication type:
- Article
An Alternative Practice Model: Residents Transform Continuity Clinic and Become Systems Thinkers.
- Published in:
- Journal of Graduate Medical Education, 2012, v. 4, n. 2, p. 232, doi. 10.4300/JGME-D-11-00133.1
- By:
- Publication type:
- Article
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.
- Published in:
- JAMA: Journal of the American Medical Association, 2021, v. 326, n. 20, p. 2043, doi. 10.1001/jama.2021.19499
- By:
- Publication type:
- Article
Symptom Clusters Seen in Adult COVID-19 Recovery Clinic Care Seekers.
- Published in:
- JGIM: Journal of General Internal Medicine, 2023, v. 38, n. 2, p. 442, doi. 10.1007/s11606-022-07908-4
- By:
- Publication type:
- Article
Capsule Commentary on Kobayashi et al., Cognitive Function and Health Literacy Decline in a Cohort of Aging English Adults.
- Published in:
- JGIM: Journal of General Internal Medicine, 2015, v. 30, n. 7, p. 1002, doi. 10.1007/s11606-015-3243-4
- By:
- Publication type:
- Article
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults -- United States, August-December 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2022, v. 71, n. 4, p. 118
- By:
- Publication type:
- Article
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions -- United States, March-August 2021.
- Published in:
- MMWR: Morbidity & Mortality Weekly Report, 2021, v. 70, n. 38, p. 1337, doi. 10.15585/mmwr.mm7038e1
- By:
- Publication type:
- Article
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article